ArticleOncoTargets and therapy2016

Interleukin-32α inactivates JAK2/STAT3 signaling and reverses interleukin-6-induced epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer cells.

Jingfeng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.